These five stocks are all growing revenue by at least 40% annually.

Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its Covid 19 vaccines. The agreement includes a ...

Chart Industries, Inc. (NYSE: GTLS) today reported results for the fourth quarter and full year ended December 31, 2025. Full ...

Fourth Quarter Revenue Increased 34.0% Year-over-Year Fourth Quarter Revenue Less Ancillary Services Increased 35.3% Year-over-Year Company Provides First Quarter and Fiscal-Year 2026 Outlook BOSTON ...

Objective This study aims to explore how age and gender are associated with health deterioration related to caregiving among caregivers aged 75 and older in Spain. Design Observational, descriptive, ...